As a new journal turning to its second volume, we are pleased to see that we have already attracted many scientists, who would like to publish their valuable studies, worldwide. This increases our motivation and makes us more confident in the pursuit of the scientific excellence, which is our ultimate goal for the upcoming issues. Our journal has just been indexed in Index Copernicus, one of the widely known and prestigious scientific indexing services. In addition to that, DOAJ (Directory of Open Access Journals), MJL (Medical Journal Links), Google Scholar, Index Scholar, Journal Index.net, and ScopeMed have also included JIHP in their master journal lists. We are trying hard to meet the prerequisites of the most widely used indexing services, such as EBSCO, NLM PubMed and Web of Science, and hoping to be accepted by at least one of them this year.
Having a look to the past, the issues of the first volume of JIHP comprised various original articles covering the human pathology and the animal science, with review articles, short communications, case reports and letters to the editors. Accepted articles in our journal came from many countries all over the world, from the U.S.A., Canada, Norway, England, Italy, Germany, Spain, Bulgaria, Estonia, India, Malaysia, Taiwan, Japan, Nigeria, Ethiopia, Tunisia, Libya, Saudi Arabia, Egypt, Argentina, and Turkey. Our acceptance rate and overall decision time is about 46 % and 29 days, respectively. After an initial editorial check, we usually forward submitted papers to at least 2 and up to 5 referees according to their expertise areas.
Last year, "Small Cell Lung Carcinoma: Better Than Its Reputation? A Population Based Study" [1] , was one of the most accessed and downloaded article among the research published in JIHP. Among the review articles published in volume 1, "Differential expression of LMP2/β1i: As a potential biomarker of human uterine mesenchymal tumors" by Dr. Takuma Hayashi from Shinshu University, Japan, is a comprehensive text in the area of gynecopathology [2] . He focused on the LMP2 protein, from its structure to the potential usage in the differential diagnosis of the uterine smooth muscle tumors.
The first issue of the new volume of JIHP starts with the fascinating review on "IgG4-related Disease of the Genitourinary Tract" by Mukul K. Divatia and Jae Y Ro [3] . Prof. Ro is a renowned pathologist, both in the U.S.A. and South Korea. He is an expert on genitourinary and lung pathology. In this comprehensive and informative paper, the authors summarize the clinical and the histopathological patterns of IgG4-related disease in genitourinary system, from the kidneys, ureters, urinary bladder, urethra, prostate gland, penis, to testes. I am sure that our readers will enjoy reading it and learn from this article.
Starting from the second volume, some rearrangements in the editorial board have been made. We are grateful to the former members of the editorial board for their enthusiastic contributions to JIHP during its infancy.
In summary, we happily see that we had a good start in the race of ever increasing number of scientific journals to the top of the excellence. At the same time, however, we are aware of the long and tough way to go lying in front of us.
We would like to thank the scientists from all over the world, who chose our journal for submitting their works. Again, we invite all our respected colleagues to send their studies to JIHP. Let us change the current paradigm which makes difficult to reach the scientific literature and promote the interdisciplinary research. We are hoping to meet you in the new issues of JIHP.
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